Delivery Order SPE2DB22D3102-SPE2DB24FL2XJ
Award Date
9/10/24
Potential Completion Date
9/11/24
Potential Value
$2.1K
Federal Agency
Defense Logistics Agency
Awardee
Amerisourcebergen Drug Corp
Ultimate Awardee
Not listed
NAICS Category
424210 - Drugs and Druggists' Sundries Merchant Wholesalers
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a federal contract award to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, by the Defense Logistics Agency (DLA), a Defense agency. The contract is for the delivery of Methylergonovine 0.2 mg/ml injectable medication, with a fixed-price ceiling value of $4,089.08 and a completion date of July 14, 2025. The contract is not set aside for any particular business type. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC)...
This federal contract award was made by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $25,646.04 firm fixed-price delivery order is for the supply of Methylergonovine 0.2 mg/ml vials. It is not designated as a set-aside contract. Amerisourcebergen Drug Corp is a subsidiary of the parent company Cencora, Inc., which does business as Amerisourcebergen. The company holds a significant $999,999,999...
This federal contract award was issued by the Medical Supply Chain division of the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp for the delivery of 4566102755 - Methylergonovine 0.2 mg/ml vials. The $1,662.94 firm fixed-price delivery order contract does not have a set-aside designation and has an ultimate completion date of October 16, 2024. Amerisourcebergen, a major pharmaceutical distributor, has been awarded numerous Indefinite Delivery Contracts (IDCs) by the DLA and other...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of 4560843660 - Methylergonovine 0.2 mg/ml vials, with a ceiling value of $1,653.27 and a performance period through May 8, 2023. The contract is a firm fixed-price agreement, with no set-aside designation indicated. Amerisourcebergen is the prime contractor, and there is no...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, for the delivery of 4,563,239,903 units of the drug Methylergonovine 0.2 mg Tablet. The contract has a ceiling value of $2,226.26 and a period of performance through January 5, 2024. It is a Firm Fixed Price Delivery Order contract. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $2,147.50 firm fixed-price delivery order is for the supply of METHYLERGONOVINE 0.2 MG/ML VLML, a pharmaceutical product. The contract has an ultimate completion date of September 30, 2022 and was awarded on September 29, 2022. Amerisourcebergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $2,347.93 firm fixed-price delivery order is for the supply of 4565150115 - Methylergonovine 0.2 mg Tablet 12s, with a completion date of July 16, 2024. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as the primary vehicle for providing a...
This federal contract award, valued at $2,873.00, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a delivery order for the supply of 4560862324 - Methylergonovine 0.2 mg/ml vials, with a performance period ending on May 9, 2023. Amerisourcebergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999 and running...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of methylergonovine 0.2 mg/ml vials, a medication used to treat postpartum hemorrhage. The contract has a ceiling value of $1,261.51 and runs through March 13, 2025. This delivery order is part of a larger Indefinite Delivery Contract (IDC) that Amerisourcebergen...
The Defense Logistics Agency (DLA) Troop Support Medical awarded a delivery order contract to Amerisourcebergen Drug Corp's Corporate Office Division to supply 4,565,550 units of the medication Methylergonovine 0.2 mg Tablet. The firm-fixed-price contract, valued at $4,134.76, has an ultimate completion date of August 23, 2024. This delivery order is part of a larger Indefinite Delivery Contract (IDC) between DLA Troop Support Medical and Amerisourcebergen, valued at up to $999,999,999 through...